CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effect...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f40d635b267c4d139155c3e53e35e55b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f40d635b267c4d139155c3e53e35e55b2021-11-18T08:29:42ZCARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.1932-620310.1371/journal.pone.0089146https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24598827/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effectively treat and manage this disease in clinic. CARP-1 functional mimetics (CFMs) are a novel class of compounds that inhibit growth of diverse cancer cell types. Here we investigated MPM cell growth suppression by the CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited MPM cell growth, in vitro, in part by stimulating apoptosis. Apoptosis by CFM-4 involved activation of pro-apoptotic stress-activated protein kinases (SAPKs) p38 and JNK, elevated CARP-1 expression, cleavage of PARP1, and loss of the oncogene c-myc as well as mitotic cyclin B1. Treatments of MPM cells with CFM-4 resulted in depletion of NF-κB signaling inhibitor ABIN1 and Inhibitory κB (IκB)α and β, while increasing expression of pro-apoptotic death receptor (DR) 4 protein. CFM-4 enhanced expression of serine-phosphorylated podoplanin and cleavage of vimetin. CFMs also attenuated biological properties of the MPM cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Both podoplanin and vimentin regulate processes of cell motility and invasion, and their expression often correlates with metastatic disease, and poor prognosis. The fact that phosphorylation of serines in the cytoplasmic domain of podoplanin interferes with processes of cellular motility, CFM-4-dependent elevated phosphorylated podoplanin and cleavage of vimentin underscore a metastasis inhibitory property of these compounds, and suggest that CFMs and/or their future analogs have potential as anti-MPM agents.Shazia JamalVino T CheriyanMagesh MuthuSara MunieEdi LeviAbdelkader E AshourHarvey I PassAnil WaliMandip SinghArun K RishiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 3, p e89146 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Shazia Jamal Vino T Cheriyan Magesh Muthu Sara Munie Edi Levi Abdelkader E Ashour Harvey I Pass Anil Wali Mandip Singh Arun K Rishi CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| description |
Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effectively treat and manage this disease in clinic. CARP-1 functional mimetics (CFMs) are a novel class of compounds that inhibit growth of diverse cancer cell types. Here we investigated MPM cell growth suppression by the CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited MPM cell growth, in vitro, in part by stimulating apoptosis. Apoptosis by CFM-4 involved activation of pro-apoptotic stress-activated protein kinases (SAPKs) p38 and JNK, elevated CARP-1 expression, cleavage of PARP1, and loss of the oncogene c-myc as well as mitotic cyclin B1. Treatments of MPM cells with CFM-4 resulted in depletion of NF-κB signaling inhibitor ABIN1 and Inhibitory κB (IκB)α and β, while increasing expression of pro-apoptotic death receptor (DR) 4 protein. CFM-4 enhanced expression of serine-phosphorylated podoplanin and cleavage of vimetin. CFMs also attenuated biological properties of the MPM cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Both podoplanin and vimentin regulate processes of cell motility and invasion, and their expression often correlates with metastatic disease, and poor prognosis. The fact that phosphorylation of serines in the cytoplasmic domain of podoplanin interferes with processes of cellular motility, CFM-4-dependent elevated phosphorylated podoplanin and cleavage of vimentin underscore a metastasis inhibitory property of these compounds, and suggest that CFMs and/or their future analogs have potential as anti-MPM agents. |
| format |
article |
| author |
Shazia Jamal Vino T Cheriyan Magesh Muthu Sara Munie Edi Levi Abdelkader E Ashour Harvey I Pass Anil Wali Mandip Singh Arun K Rishi |
| author_facet |
Shazia Jamal Vino T Cheriyan Magesh Muthu Sara Munie Edi Levi Abdelkader E Ashour Harvey I Pass Anil Wali Mandip Singh Arun K Rishi |
| author_sort |
Shazia Jamal |
| title |
CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| title_short |
CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| title_full |
CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| title_fullStr |
CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| title_full_unstemmed |
CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| title_sort |
carp-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b |
| work_keys_str_mv |
AT shaziajamal carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT vinotcheriyan carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT mageshmuthu carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT saramunie carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT edilevi carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT abdelkadereashour carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT harveyipass carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT anilwali carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT mandipsingh carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells AT arunkrishi carp1functionalmimeticsareanovelclassofsmallmoleculeinhibitorsofmalignantpleuralmesotheliomacells |
| _version_ |
1718421778827575296 |